ARCHIVES

In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35%

This article is from The Cancer Letter archive.

Vol. 03 No. 41 | October 14, 1977

Download PDF Visit The Full Archive

Related Articles

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

With workload Up, Oncology Division To Add More Staff

August 2, 1996

Capitol Hill: Mammography Quality standards Act Reintroduced

April 18, 1997

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

Emerging Technologies: Company To Expand Program Studying Polymer Platinates

June 1, 2001